Technological advancements for the detection of and protection against biological and chemical warfare agents

被引:187
作者
Eubanks, Lisa M.
Dickerson, Tobin J.
Janda, Kim D.
机构
[1] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA
关键词
D O I
10.1039/b615227a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There is a growing need for technological advancements to combat agents of chemical and biological warfare, particularly in the context of the deliberate use of a chemical and/or biological warfare agent by a terrorist organization. In this tutorial review, we describe methods that have been developed both for the specific detection of biological and chemical warfare agents in a field setting, as well as potential therapeutic approaches for treating exposure to these toxic species. In particular, nerve agents are described as a typical chemical warfare agent, and the two potent biothreat agents, anthrax and botulinum neurotoxin, are used as illustrative examples of potent weapons for which countermeasures are urgently needed.
引用
收藏
页码:458 / 470
页数:13
相关论文
共 51 条
[1]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[2]  
Ashley JA, 1999, ANGEW CHEM INT EDIT, V38, P1793, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1793::AID-ANIE1793>3.0.CO
[3]  
2-U
[4]   Management of anthrax [J].
Bartlett, JG ;
Inglesby, TV ;
Borio, L .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) :851-858
[5]   Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry [J].
Boldt, GE ;
Kennedy, JP ;
Janda, KD .
ORGANIC LETTERS, 2006, 8 (08) :1729-1732
[6]   Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin A inhibitors [J].
Boldt, Grant E. ;
Kennedy, Jack P. ;
Hixon, Mark S. ;
McAllister, Laura A. ;
Barbieri, Joseph T. ;
Tzipori, Saul ;
Janda, Kim D. .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2006, 8 (04) :513-521
[7]   Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model [J].
Boldt, Grant E. ;
Eubanks, Lisa M. ;
Janda, Kim D. .
CHEMICAL COMMUNICATIONS, 2006, (29) :3063-3065
[8]  
BOROFF DA, 1967, J ALB EINSTEIN MED C, V15, P22
[9]   Molecular basis for improved anthrax vaccines [J].
Brey, RN .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (09) :1266-1292
[10]   The evolving field of biodefence: Therapeutic developments and diagnostics [J].
Burnett, JC ;
Henchal, EA ;
Schmaljohn, AL ;
Bavari, S .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (04) :281-297